Authors:
TUTT AL
FRENCH RR
ILLIDGE TM
HONEYCHURCH J
MCBRIDE HM
PENFOLD CA
FEARON DT
PARKHOUSE RME
KLAUS GGB
GLENNIE MJ
Citation: Al. Tutt et al., MONOCLONAL-ANTIBODY THERAPY OF B-CELL LYMPHOMA - SIGNALING ACTIVITY ON TUMOR-CELLS APPEARS MORE IMPORTANT THAN RECRUITMENT OF EFFECTORS, The Journal of immunology (1950), 161(6), 1998, pp. 3176-3185
Citation: Cht. Chan et al., INTERNALIZATION OF THE LYMPHOCYTIC SURFACE PROTEIN CD22 IS CONTROLLEDBY A NOVEL MEMBRANE PROXIMAL CYTOPLASMIC MOTIF, The Journal of biological chemistry, 273(43), 1998, pp. 27809-27815
Citation: Jcj. Alberts et al., [ANTI-17.1A X ANTI-CD3] F(AB')(2) BISPECIFIC ANTIBODY INHIBITS GROWTHOF PULMONARY METASTESES IN MICE BEARING SYNGENEIC 17.1A-TRANSFECTED TUMOR, British Journal of Surgery, 85, 1998, pp. 80-80
Authors:
SFORZINI S
DETOTERO D
GAGGERO A
IPPOLITI R
GLENNIE MJ
CANEVARI S
STEIN H
FERRINI S
Citation: S. Sforzini et al., TARGETING OF SAPORIN TO HODGKINS LYMPHOMA-CELLS BY ANTI-CD30 AND ANTI-CD25 BISPECIFIC ANTIBODIES, British Journal of Haematology, 102(4), 1998, pp. 1061-1068
Authors:
ILLIDGE TM
ERENPREISA J
CRAGG MS
GLENNIE MJ
Citation: Tm. Illidge et al., CAFFEINE POTENTIATES CELL-DEATH IN P53 MUTATED RADIORESISTANT BURKITTS-LYMPHOMA CELLS BY APOPTOSIS AND INCREASING THE FORMATION OF GIANT-CELLS, British Journal of Cancer, 78, 1998, pp. 11-11
Citation: Tm. Illidge et al., RADIOIMMUNOTHERAPY OF B-CELL LYMPHOMAS WITH I-131-LABELED ANTIBODIES - DETERMINANTS OF SUCCESSFUL THERAPY, British Journal of Cancer, 78, 1998, pp. 53-53
Citation: Iafm. Heijnen et al., LYSIS OF MURINE B-LYMPHOMA-CELLS BY TRANSGENIC PHAGOCYTES VIA A HUMANFC-GAMMA-RI X MURINE MHC CLASS-II BISPECIFIC ANTIBODY, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 166-170
Authors:
HONEYCHURCH J
CRUISE A
TUTT AL
GLENNIE MJ
Citation: J. Honeychurch et al., BISPECIFIC AB THERAPY OF B-CELL LYMPHOMA - TARGET-CELL SPECIFICITY OFANTIBODY DERIVATIVES APPEARS CRITICAL IN DETERMINING THERAPEUTIC OUTCOME, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 171-173
Citation: Ml. Lang et al., HUMAN NEUTROPHIL FC-ALPHA-R AND FC-GAMMA-RIIA BUT NOT FC-GAMMA-RIIIB GENERATE INTRACELLULAR CALCIUM SIGNALS WHICH TRIGGER THE RESPIRATORY BURST, Biochemical Society transactions, 25(2), 1997, pp. 333-333
Authors:
PERFETTI V
VIGNARELLI MC
BELLOTTI V
GLENNIE MJ
ZORZOLI I
UBBIALI P
OBICI L
MASSA M
IPPOLITI G
ASCARI E
MERLINI G
Citation: V. Perfetti et al., MEMBRANE CD22 DEFINES CIRCULATING MYELOMA-RELATED CELLS AS MATURE OR LATER B-CELLS, Laboratory investigation, 77(4), 1997, pp. 333-344
Authors:
HEIJNEN IAFM
RIJKS LJM
SCHIEL A
STOCKMEYER B
VANOJIK HH
DECHANT M
VALERIUS T
KELER T
TUTT AL
GLENNIE MJ
VANROYEN EA
CAPEL PJA
VANDEWINKEL JGJ
Citation: Iafm. Heijnen et al., GENERATION OF HER-2 NEU-SPECIFIC CYTOTOXIC NEUTROPHILS IN-VIVO - EFFICIENT ARMING OF NEUTROPHILS BY COMBINED ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND FC-GAMMA RECEPTOR-I BISPECIFIC ANTIBODIES/, The Journal of immunology, 159(11), 1997, pp. 5629-5639
Authors:
FRENCH RR
BELL AJ
HAMBLIN TJ
TUTT AL
GLENNIE MJ
Citation: Rr. French et al., RESPONSE OF B-CELL LYMPHOMA TO A COMBINATION OF BISPECIFIC ANTIBODIESAND SAPORIN, Leukemia research, 20(7), 1996, pp. 607-617
Authors:
BERGAMASCHI G
PERFETTI V
TONON L
NOVELLA A
LUCOTTI C
DANOVA M
GLENNIE MJ
MERLINI G
CAZZOLA M
Citation: G. Bergamaschi et al., SAPORIN, A RIBOSOME-INACTIVATING PROTEIN USED TO PREPARE IMMUNOTOXINS, INDUCES CELL-DEATH VIA APOPTOSIS, British Journal of Haematology, 93(4), 1996, pp. 789-794
Authors:
ELASSER D
VALERIUS T
REPP R
WEINER GJ
DEO Y
KALDEN JR
VANDEWINKEL JGJ
STEVENSON GT
GLENNIE MJ
GRAMATZKI M
Citation: D. Elasser et al., HLA CLASS-II AS POTENTIAL TARGET ANTIGEN ON MALIGNANT B-CELLS FOR THERAPY WITH BISPECIFIC ANTIBODIES IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, Blood, 87(9), 1996, pp. 3803-3812
Citation: Al. Tutt et al., ACTIVATION AND PREFERENTIAL EXPANSION OF RAT CYTOTOXIC (CD8) T-CELLS IN-VITRO AND IN-VIVO WITH A BISPECIFIC (ANTI-TCR-ALPHA BETA X ANTI-CD2)F(AB')(2) ANTIBODY/, The Journal of immunology, 155(6), 1995, pp. 2960-2971
Authors:
ELLIS JH
BARBER KA
TUTT A
HALE C
LEWIS AP
GLENNIE MJ
STEVENSON GT
CROWE JS
Citation: Jh. Ellis et al., ENGINEERED ANTI-CD38 MONOCLONAL-ANTIBODIES FOR IMMUNOTHERAPY OF MULTIPLE-MYELOMA, The Journal of immunology, 155(2), 1995, pp. 925-937
Citation: Ajt. George et al., MEASUREMENT OF KINETIC BINDING CONSTANTS OF A PANEL OF ANTI-SAPORIN ANTIBODIES USING A RESONANT MIRROR BIOSENSOR, Journal of immunological methods, 183(1), 1995, pp. 51-63
Authors:
FRENCH RR
PENNEY CA
BROWNING AC
STIRPE F
GEORGE AJT
GLENNIE MJ
Citation: Rr. French et al., DELIVERY OF THE RIBOSOME-INACTIVATING PROTEIN, GELONIN, TO LYMPHOMA-CELLS VIA CD22 AND CD38 USING BISPECIFIC ANTIBODIES, British Journal of Cancer, 71(5), 1995, pp. 986-994
Authors:
BERGAMASCHI G
PERFETTI V
TONON L
NOVELLA A
LUCOTTI C
DANOVA M
GLENNIE MJ
MERLINI G
CAZZOLA M
Citation: G. Bergamaschi et al., SAPORIN INDUCES CELL-DEATH VIA APOPTOSIS - STUDIES WITH BISPECIFIC ANTIBODIES THAT RECOGNIZE BOTH SAPORIN AND CD22, Blood, 86(10), 1995, pp. 1262-1262
Authors:
VALERIUS T
REPP R
ELSASSER D
WURFLEIN D
WEINER GJ
DEO Y
KALDEN JR
VANDEWINKEL JJG
GLENNIE MJ
GRAMATZKI M
Citation: T. Valerius et al., HLA CLASS-II AS POTENTIAL TARGET ANTIGEN ON MALIGNANT B-CELLS FOR THERAPY WITH BISPECIFIC ANTIBODIES IN COMBINATION WITH G-CSF, Blood, 86(10), 1995, pp. 2132-2132
Authors:
BONARDI MA
FRENCH RR
AMLOT P
MODENA D
GLENNIE MJ
Citation: Ma. Bonardi et al., DELIVERY OF SAPORIN TO HUMAN B-CELL LYMPHOMA USING BISPECIFIC ANTIBODY - TARGETING VIA CD22 BUT NOT CD19, CD37, OR IMMUNOGLOBULIN RESULTS IN EFFICIENT KILLING, Cancer research, 53(13), 1993, pp. 3015-3021
Authors:
HAMBLIN TJ
BELL AJ
MEAD G
SADULLAH S
FRENCH RR
GLENNIE MJ
STEVENSON FK
STEVENSON GT
Citation: Tj. Hamblin et al., A COMPARISON OF BISPECIFIC ANTIBODY SAPORIN COMPLEXES AND CHIMERIC MOUSE FAB HUMAN BIS-FC ANTIBODIES IN THE TREATMENT OF LOW-GRADE LYMPHOMA, British Journal of Haematology, 84, 1993, pp. 14-14